Literature DB >> 12720117

Defining Waldenstrom's macroglobulinemia.

Steven P Treon1, Meletios Dimopoulos, Robert A Kyle.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12720117     DOI： 10.1053/sonc.2003.50081

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  5 in total

1.  Src tyrosine kinase regulates adhesion and chemotaxis in Waldenstrom macroglobulinemia.

Authors:  Hai T Ngo; Abdel Kareem Azab; Mena Farag; Xiaoying Jia; Molly M Melhem; Judith Runnels; Aldo M Roccaro; Feda Azab; Antonio Sacco; Xavier Leleu; Kenneth C Anderson; Irene M Ghobrial
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

2.  Pathophysiology of Waldenström's macroglobulinemia.

Authors:  Marvin J Stone; Virginia Pascual
Journal:  Haematologica       Date:  2010-03       Impact factor: 9.941

3.  The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia.

Authors:  Xavier Leleu; Xiaoying Jia; Judith Runnels; Hai T Ngo; Anne-Sophie Moreau; Mena Farag; Joel A Spencer; Costas M Pitsillides; Evdoxia Hatjiharissi; Aldo Roccaro; Garrett O'Sullivan; Douglas W McMillin; Daisy Moreno; Tanyel Kiziltepe; Ruben Carrasco; Steven P Treon; Teru Hideshima; Kenneth C Anderson; Charles P Lin; Irene M Ghobrial
Journal:  Blood       Date:  2007-08-30       Impact factor: 22.113

Review 4.  Novel therapeutic agents in Waldenström's macroglobulinemia.

Authors:  Irene M Ghobrial; Xavier Leleu; Abdel Kareem Azab; Judith Runnels; Xiaoying Jia; Hai Ngo; Molly Melhem; Feda Azab; Antonio Sacco; Phong Quang; Nicholas Burwick; Anne-Sophie Moreau; Emanuel Husu; Mena Farag; Aldo Roccaro
Journal:  Clin Lymphoma Myeloma       Date:  2009-03

5.  Cause-specific mortality in individuals with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia, 2000-2016.

Authors:  Nicole H Dalal; Graça M Dores; Rochelle E Curtis; Martha S Linet; Lindsay M Morton
Journal:  Br J Haematol       Date:  2020-02-23       Impact factor: 8.615
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.